Golotimod clinical trials
Also written SCV-07.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses golotimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- SCV-07
- 3
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
SciClone Pharmaceuticals (3)
Studies
Open first, then newest update. How each study uses golotimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck CancerStatus unknownPhase 2SciClone PharmaceuticalsNCT01247246Written as SCV-07
- Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have RelapsedCompletedPhase 2SciClone PharmaceuticalsNCT00968357Written as SCV-07
- Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck CancerCompletedPhase 2SciClone PharmaceuticalsNCT00756951Written as SCV-07
Codes
What other systems call golotimod · ClinicalTrials.gg INT004498
- MeSH (NLM) C470075golotimodOne source NLM
- UNII (FDA) 637C487Y09GOLOTIMODConfirmed FDA, NLM, Wikidata
- RxNorm 2367440One source FDA
- Wikidata Q27095684golotimodConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76497GolotimodOne source FDA
- DrugBank DB05475One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C470075 | golotimod | One source NLM |
| UNII (FDA) | 637C487Y09 | GOLOTIMOD | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2367440 | — | One source FDA |
| Wikidata | Q27095684 | golotimod | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76497 | Golotimod | One source FDA |
| DrugBank | DB05475 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.